Search with one or more keywords

This page gives you access to all the studies carried out by French researchers, identified on Covid-19.

To view other resources related to Covid-19, click here.

xml
XML

Export to XML

Please choose the format :

XML
XML-DDI
pdf
PDF

Export to PDF

Which version do you want to export ?

Download full content
Download light content
csv
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection
Export to CSV

Covid-19 : 84 forms

Sorting of results :

COCO_LATE - Clinical events occurring within 6 months of SARS-COV-2 infection: multicentre cohort

Head : ROBINEAU Olivier

Version 1
Voir
View
Overview

49

Last update : 05/06/2021

COCO_LATE - Clinical events occurring within 6 months of SARS-COV-2 infection: multicentre cohort

Head : ROBINEAU Olivier

Main objective

Describe, over time, the symptoms presented by patients reporting persistent symptoms (more than two months after onset) or onset of symptoms more than 3 weeks after the beginning of symptomatic SARS-CoV-2 (COVID-19) infection evidenced by laboratory tests.

Inclusion criteria

1- History of symptomatic SARS-CoV-2 infection defined by:
A positive RT-PCR result for SARS-CoV-2 OR positive SARS-CoV-2 serology combined with at least one event:
- Anosmia occurring after February 2020
- OR CT scan consistent with COVID-19
- OR ? 2 symptoms coinciding with the virology sample, including: asthenia, cough, dyspnoea, fever, myalgia, dysgeusia, diarrhoea AND not present prior to diagnosis
2- AND persistence of at least one symptom present in the first 3 weeks of COVID-19, more than 8 weeks after the first COVID symptoms
OR late onset of at least one new symptom at least 3 weeks and not more than 6 months after the first symptoms of SARS-CoV-2 infection
3- First symptoms within the past 6 months on the date of inclusion
4- Beneficiary of a health insurance scheme or the state welfare scheme
5- Having signed an informed consent form at inclusion

Last update : 05/06/2021

Voir
View

PEDONCOVID - SFCE national cohort on SARS-CoV-2 (COVID-19) infections in paediatric oncology-haematology

Head : ROUGER-GAUDICHON Jérémie

Version 1
Voir
View
Overview

50

Last update : 05/05/2021

PEDONCOVID - SFCE national cohort on SARS-CoV-2 (COVID-19) infections in paediatric oncology-haematology

Head : ROUGER-GAUDICHON Jérémie

Main objective

Describe the presentation and clinical course of SARS-CoV-2 infection among patients followed up in a paediatric oncology-haematology department or young adult and adolescent unit at an SFCE centre, for cancer or a benign tumour treated with chemotherapy, radiotherapy or targeted therapy.

Inclusion criteria

Children and legal representatives, or adult patients having received information on the study
AND
- Patient followed up in a paediatric oncology-haematology department or young adult and adolescent unit at an SFCE centre for cancer or a benign tumour treated with chemotherapy, radiotherapy or targeted therapy, with a cancer treatment either ongoing or completed within the past 6 months, or a history of allogeneic haematopoietic stem cell transplantation with immunosuppressant therapy ongoing or discontinued within the past 6 months, or a history of CAR-T cell therapy
AND
- Diagnosis of SARS-CoV-2 infection confirmed by PCR or positive IgM serology
OR
- Clinical and radiological diagnosis characteristic of SARS-CoV-2 infection without confirmation of infection by PCR or positive IgM serology with:
o Presence of at least 2 of the following signs in the event of contact with a subject currently presenting SARS-CoV-2 positive infection, or 3 of the following signs in the absence of contact: fever, cough, dysgeusia, dysosmia, myalgia, chest pain, dyspnoea, signs of respiratory distress, rhinorrhoea or nasopharyngeal congestion, diarrhoea, headaches, recent onset or exacerbation of asthenia and rash.
AND
o One or more radiological abnormalities observed on chest CT scan compatible with a diagnosis of COVID-19: peripheral and/or subpleural and/or bilateral ground-glass opacities, intralobular thickening with a “crazy-paving” appearance, linear condensations with or without peripheral halo (reverse halo sign).

Last update : 05/05/2021

Voir
View

COVID-IMPACT - Prevalence and Development of Post-traumatic Stress Disorder and Anxiety and Depressive Symptoms Among AP-HP Staff During the Covid-19 Epidemic

Head : PELISSOLO Antoine , Psychiatry

Version 1
Voir
View
Overview

51

Last update : 01/29/2021

COVID-IMPACT - Prevalence and Development of Post-traumatic Stress Disorder and Anxiety and Depressive Symptoms Among AP-HP Staff During the Covid-19 Epidemic

Head : PELISSOLO Antoine , Psychiatry

Main objective

The epidemic of coronavirus induces a major influx of patients implying a rapid modification of the organizations, a work overload and a significant stress for the care teams and supports of the hospitals of the Assistance Publique - Hôpitaux de Paris (AP-HP) . To this is added the impact on each professional of the large number of very severe patients to be treated, of death and the anxiety of contamination, reinforced by the actual cases of staff themselves sick. Emergency phone numbers for professionals in the event of psychological suffering were quickly put in place at the AP-HP and Hospitals level. The objective of this study is to assess the psychopathological and psycho-traumatic consequences of this exceptional situation on the staff, during the epidemic and at a distance from it, in order to be able to target the solutions to be implemented. Hypothesis is that some personnel may develop one or more of the following disorders: adjustment disorder or other anxiety disorder, acute stress disorder, post-traumatic stress disorder (PTSD), and depressive episodes as defined in the DSM-5. This study also aimes to assess effect of support measures put in place, by comparing the evolution of those who benefited from those who did not use them, as well as the risk factors specific. The results will make it possible to have an estimate of the percentage of people who may require specific support, and to identify the staff most at risk, and thus predict the importance of the circuits and structures for support of staff which will be necessary in the short and long term. The main anticipated risk factors are: being a nurse, having a low number of years of professional experience, and being on the front line of care for affected patients.

Inclusion criteria

Inclusion Criteria:

AP-HP professionals on duty during the COVID epidemic agreeing to participate in the three stages of the study.

Exclusion Criteria:

none

Last update : 01/29/2021

Voir
View

DénutCOVID - Nutritional evaluation of COVID patients hospitalised in the COVID units at St VINCENT Hospital.

Head : Dr Cortet Arnaud

Version 1
Voir
View
Overview

52

Last update : 05/07/2021

DénutCOVID - Nutritional evaluation of COVID patients hospitalised in the COVID units at St VINCENT Hospital.

Head : Dr Cortet Arnaud

Main objective

Evaluate the initial nutritional status of COVID patients hospitalised in standard COVID units (not in intensive care units).

Inclusion criteria

Inclusion criteria:
o Patient admitted to a standard hospital department within the past 72 hrs,
o Age > 18 years,
o Covid-19 diagnosis confirmed by positive RT-PCR
o Patient agreeing to take part in the study
o Patient registered with a social security scheme

Exclusion criteria:
o Prior hospitalisation in critical care (intensive care unit) for more than 72 hours due to the risk of biased nutritional status analysis.

Last update : 05/07/2021

Voir
View

PreCARES - “Poverty and Covid-19: changes in access and recourse to health care”, Île-de-France March-June 2020

Head : Véran Jean François

Version 1
Voir
View
Overview

53

Last update : 05/05/2021

PreCARES - “Poverty and Covid-19: changes in access and recourse to health care”, Île-de-France March-June 2020

Head : Véran Jean François

Main objective

The study set itself the objective of investigating and documenting the way in which vulnerable populations coped with the lockdown period for controlling the Covid-19 crisis, in terms of the following three aspects: 1) The effects of reducing the public space, access to resources and available services and health care, limiting the ability of vulnerable populations to look after themselves, particularly in terms of health. 2) The way in which public policies for the Covid-19 epidemic were applied - or not - in practical situations facing vulnerable populations. 3) The ability of the stakeholders - including MSF - to offer a solution to health problems arising among these populations, both in terms of the epidemic, and more general health needs.

Inclusion criteria

The study population concerned vulnerable individuals aged over 15 years, randomly and proportionally selected at each study site. The study sites were selected out of convenience, to fulfil the following criteria: sites still open and at which the MSF Covid Poverty project intervened at least once to provide medical and paramedical care, in the Paris and Seine Saint Denis administrative departments (main geographical zone of the MSF project), accepting populations suffering from economic and/or administrative instability, representing diverse forms of housing and accommodations, where the safety conditions at the time of the survey permitted, and after approval by the head of the association or housing facility.

Last update : 05/05/2021

Voir
View

Psy-GIPO2C - Psychiatry Professionals and Covid 19 in Europe: Psychological Impact Management and Crisis and Post-Crisis Organisation

Head : Frédéric DENIS

Version 1
Voir
View
Overview

54

Last update : 01/09/2021

Psy-GIPO2C - Psychiatry Professionals and Covid 19 in Europe: Psychological Impact Management and Crisis and Post-Crisis Organisation

Head : Frédéric DENIS

Main objective

The project will provide an intelligent, European-wide perspective, to enable the sharing of innovative practices in a very operational manner.

Inclusion criteria

Approximately 2,000 psychiatric care professionals,

Last update : 01/09/2021

Voir
View

Please wait...

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05

View Edit Create here